Janet Macpherson (she/her)

@BLLPHD @DrPHanley @ISCTglobal @carlhjune @PennMedicine @ChildrensPhila Absolutely the best news. Well deserved Bruce. Honoured to count you as one of those who first welcomed me to ISHAGE and cell therapy.

I'm deeply honored to receive the @ISCTglobal Career Achievement Award. This recognition reflects the efforts of many in the Center for Cellular Immunotherapies directed by @carlhjune, and collaborators @PennMedicine & @ChildrensPhila. I'm grateful to ISCT for decades of support, & the insight & friendship of my ISCT colleagues. isctglobal.org/about/major-aw…

@theAGCTS meeting is in Sydney next week. Looking forward to reconnecting with Cell and Gene Therapy colleagues. See you there? #AGCTS

Join n-Lorem Foundation's 2024 Nano-Rare Patient Colloquium. This year’s colloquium will bring together patients, physicians, and supporters to create a cohesive, empathetic, and knowledgeable nano-rare community. This event is open to all—register now! linkedin.com/posts/nlorem_n…

A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that envelop genetic material of adeno-associated viruses (AAV), to improve gene therapies for muscle diseases. medicalxpress.com/news/2024-09-g…

BioMolecular Horizons is in Melbourne this coming week26th IUBMB 17th FAOBMB 22nd ComBio Swing by Cytiva's booth to explore breakthrough solutions and chat with our specialists to shape the future of research together. cytiva.link/h518x

Great commentary on the topic of in vivo CAR T therapy> Drug developers want to reprogram immune cells directly in the body, opening up new gene therapy frontiers in cancer and autoimmunity. nature.com/articles/d4157…

Cytiva is aware that tackling scope 3 emissions can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review: cytiva.link/j1es6.

Oh wow, this is some great news. Need to read the details!

Enter for the opportunity to have your cell image on the cover of @cytotherapy Thanks @ISCTglobal

The Guidelines for minimal information on cellular senescence experimentation #MICSE are now available @CellCellPress: "...an overview of senescence markers in rodent tissues, transgenic models, non-mammalian systems, human tissues, and tumors and their use in the identification and specification of senescent cells." Thanks to the leadership of Mikolaj Ogrodnik, Johannes Grillari, Marco Demaria @marc_dema @LBG_SHoW and arising in part from a productive Wiggers-Bernard conference authors.elsevier.com/sd/article/S00…

The ISCT Early Stage Professionals Committee is looking for dedicated and enthusiastic new members to support current and upcoming programs. Join our CGT community today to foster global connections and progress your career. Learn more: buff.ly/3SK1uQ7

Loved the ISCT ANZ poster session! Great opportunity for discussion, networking, and talking about research. So impressed by all the amazing work happening in our region! @ISCTglobal @ISCT_ESP #isctanz2024 #cellandgenetherapy @EmilyBlyth5 @jmacpher @eom_jennifer @bio_ora

@AliciaD_nz @ISCTglobal @ISCT_ESP @EmilyBlyth5 @eom_jennifer @bio_ora We just need a bit more space

#ISCTANZ2024 even more spectacular today as the main meeting gets underway. In the joint @ISCTglobal AND @theASSCR joint session. Here @jmacpher presents data on non-viral lipid nano particles for gene editing of CD34 stem cells.

See you next week in Queenstown NZ for #ISCTANZ2024 linkedin.com/posts/janet-ma…

We've been busy eliminating polystyrene in packaging. Our new packaging has liners made with renewable paper and corn starch as their primary ingredients.

Did you miss the future of oligo synthesis? Don't worry, you can now access it on-demand webinar. Watch now and learn how a unicorn's magic powers can bring you up to speed as quickly as possible: event.webcasts.com/starthere.jsp?…

Thinking about bringing your oligo process in-house? It's a brave decision. Find out if it is for you Explore what it entails and the benefits of owning your process in our on-demand webinar. event.webcasts.com/starthere.jsp?…

Calling all ÄKTA oligosynt users! Boost your yields in oligo synthesis in less than 30 minutes with our on-demand webinar. : event.webcasts.com/starthere.jsp?…

📢 The application #deadline has been extended to 2 July 2024 – apply now! 🏃‍♂️Last chance to join this year’s edition. 🔗 esact.org/gene-cell-ther…